Cargando…

Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa

Following the first triple-drug mass drug administration (MDA) for lymphatic filariasis in Samoa in 2018, unexpected persistence of microfilaria (Mf) positivity in 18 (15%) of 121 antigen-positive persons was observed in a nationwide household survey 1–2 months later. Of the 18 Mf positive persons,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graves, Patricia M., Sheridan, Sarah, Scott, Jessica, Amosa-Lei Sam, Filipina, Naseri, Take, Thomsen, Robert, King, Christopher L., Lau, Colleen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167748/ https://www.ncbi.nlm.nih.gov/pubmed/33916264 http://dx.doi.org/10.3390/tropicalmed6020044

Ejemplares similares

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018
por: Willis, Gabriela A., et al.
Publicado: (2020)

Lymphatic filariasis epidemiology in Samoa in 2018: Geographic clustering and higher antigen prevalence in older age groups
por: Lau, Colleen L., et al.
Publicado: (2020)

Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019
por: Willis, Gabriela A., et al.
Publicado: (2023)

Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019
por: McPherson, Brady, et al.
Publicado: (2022)

Supporting elimination of lymphatic filariasis in Samoa by predicting locations of residual infection using machine learning and geostatistics
por: Mayfield, Helen J., et al.
Publicado: (2020)

Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2021)

Burden of hydrocoele assessed from medical and surgical records in a lymphatic filariasis endemic country, Samoa
por: Ah Leong-Lui, Tile A., et al.
Publicado: (2019)

Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014
por: Graves, Patricia M., et al.
Publicado: (2020)

Is Samoa Prepared for an Outbreak of COVID-19?
por: Olayemi, Lawal Olatunde, et al.
Publicado: (2020)

Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame
por: Lau, Colleen L., et al.
Publicado: (2016)

Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration
por: Coutts, Shaun P., et al.
Publicado: (2017)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration
por: Lau, Colleen L., et al.
Publicado: (2017)

Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration
por: Lau, Colleen L., et al.
Publicado: (2014)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods
por: Wangdi, Kinley, et al.
Publicado: (2022)

Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa
por: Lemin, Morgan E., et al.
Publicado: (2022)

Spatial predictive risk mapping of lymphatic filariasis residual hotspots in American Samoa using demographic and environmental factors
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2023)

Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa
por: Shaw, Callum, et al.
Publicado: (2023)

Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016
por: Sheel, Meru, et al.
Publicado: (2018)

Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post–mass drug ad ministration surveillance in American Samoa
por: Cadavid Restrepo, Angela M., et al.
Publicado: (2022)

Knowledge and Attitudes of Pacific Islander Doctors and Medical Students to Childhood Hearing Loss and Hearing Services: Results of a Structured Questionnaire Survey in SAMOA
por: Kaspar, Annette, et al.
Publicado: (2022)

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing ‘number needed to test’ by targeting older age groups, hotspots, and household members of infected persons
por: Lau, Colleen L., et al.
Publicado: (2020)

Enhanced surveillance for the Third United Nations Conference on Small Island Developing States, Apia, Samoa, September 2014
por: White, Paul, et al.
Publicado: (2017)

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa
por: Won, Kimberly Y., et al.
Publicado: (2018)

Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
por: Irvine, Michael A., et al.
Publicado: (2016)

Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa
por: Schmaedick, Mark A., et al.
Publicado: (2014)

The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific
por: Rainima-Qaniuci, Merelesita, et al.
Publicado: (2022)

Adapting the WHO package of essential noncommunicable disease interventions, Samoa
por: Bollars, Caroline, et al.
Publicado: (2018)

Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific
por: Joseph, Hayley, et al.
Publicado: (2011)

Lymphatic filariasis mapping by Immunochromatographic Test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone
por: Koroma, Joseph B, et al.
Publicado: (2012)

Leptospirosis, American Samoa
por: Lau, Colleen L., et al.
Publicado: (2012)

Tobacco smoking patterns in Samoa in 2010: Implications for interventions
por: Adia, Alexander C., et al.
Publicado: (2019)

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities
por: Biritwum, Nana Kwadwo, et al.
Publicado: (2019)

A Synthetic Population for Modelling the Dynamics of Infectious Disease Transmission in American Samoa
por: Xu, Zhijing, et al.
Publicado: (2017)

Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2017)

The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
por: Kimura, Eisaku
Publicado: (2011)

Cytological diagnosis of microfilariae in filariasis endemic areas of eastern Uttar Pradesh
por: Mitra, Shaila K, et al.
Publicado: (2009)

A Randomized Trial of a New Triple Drug Treatment for Lymphatic Filariasis
por: King, Christopher L., et al.
Publicado: (2018)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

COVID-19 vaccines: Getting Anti-vaxxers involved in the discussion
por: Boodoosingh, Ramona, et al.
Publicado: (2020)

Associations between socioeconomic resources and adiposity traits in adults: Evidence from Samoa
por: Choy, Courtney C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e20pgnee1kh1k3g5tnb860fggd